524572
PHARMAID
Start SIP
Invest Now
Start SIP in PHARMAID
Performance
- Low
- ₹38
- High
- ₹40
- 52 Week Low
- ₹37
- 52 Week High
- ₹76
- Open Price₹40
- Previous Close₹40
- Volume7,761
- 50 DMA₹44.60
- 100 DMA₹48.13
- 200 DMA₹52.32
Investment Returns
- Over 1 Month -20.02%
- Over 3 Month -17.05%
- Over 6 Month -39.84%
- Over 1 Year -43.11%
Smart Investing Starts Here Start SIP with Pharmaids Pharmaceuticals for Steady Growth!
Pharmaids Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -9.7
- PEG Ratio
- 0.8
- Market Cap Cr
- 134
- P/B Ratio
- 2.6
- Average True Range
- 3.02
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.93
- RSI
- 33.61
- MFI
- 21.21
Pharmaids Pharmaceuticals Financials
Pharmaids Pharmaceuticals Technicals
EMA & SMA
Current Price
₹38.00
-1.87
(-4.69%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹41.48
- 50 Day
- ₹44.60
- 100 Day
- ₹48.13
- 200 Day
- ₹52.32
Resistance and Support
38.66
- R3 41.35
- R2 40.67
- R1 39.34
- S1 37.33
- S2 36.65
- S3 35.32
Pharmaids Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-12 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-07 | Quarterly Results | |
| 2025-05-23 | Audited Results | |
| 2025-02-12 | Quarterly Results |
Pharmaids Pharmaceuticals F&O
About Pharmaids Pharmaceuticals
- NSE Symbol
- PHARMAID
- BSE Symbol
- 524572
- ISIN
- INE117D01018
Similar Stocks to Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals FAQs
Pharmaids Pharmaceuticals share price is ₹38 As on 15 February, 2026 | 04:32
The Market Cap of Pharmaids Pharmaceuticals is ₹134 Cr As on 15 February, 2026 | 04:32
The P/E ratio of Pharmaids Pharmaceuticals is -9.7 As on 15 February, 2026 | 04:32
The PB ratio of Pharmaids Pharmaceuticals is 2.6 As on 15 February, 2026 | 04:32
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.